However, PARP6 shows a duality, acting differently on the expression and stability of the Survivin protein, proliferation, and migration, in one case as an oncoprotein in gastric cancer models [64], and conversely, acting as a suppressor protein of malignancy in colorectal cancer models [62]. Here, PARP6 is linked to colorectal cancer.